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ImmunopathologyIn animal models of inﬂuenza, systemic weight loss is the primary indicator of morbidity from infection,
which does not assess local lung pathology or the immune response. Here, we used a mouse-adapted pulse-
oximeter as a non-invasive clinical readout of lung function during inﬂuenza infection in mice, and found
direct correlations between oxygen saturation levels and lung pathology, that reﬂected the morbidity and
survival from inﬂuenza infection. We found blood oxygen levels to be a more accurate assessment than
weight-loss morbidity in predicting lung pathology in hosts infected with different viral doses, and in
assessing immune-mediated viral clearance in the lung.© 2009 Elsevier Inc. All rights reserved.IntroductionRespiratory virus infections such as inﬂuenza trigger inﬂammatory
responses both systemically and at the site of infection in the lung. The
systemic release of inﬂammatory cytokines from host immune cells is
associated with weight-loss morbidity in animal models of inﬂuenza
(La Gruta et al., 2007), andwithmortality in humans infectedwith the
pandemic 1918 inﬂuenza and avian inﬂuenza (H5N1) strains (Hsieh
et al., 2006). In the lung, inﬂuenza infection leads to virus-associated
epithelial damage, and to local immune and inﬂammatory responses
leading to pneumonia (Taubenberger and Morens, 2008). The
contribution of systemic and local lung responses to inﬂuenza mor-
bidity, and the predictive value of measuring systemic versus local
lung responses in determining the outcome of inﬂuenza infection
have not been established.
The “gold-standard” of evaluating morbidity in murine models of
viral disease including inﬂuenza, is measuring the percentage of body
weight lost during the course of infection (Mozdzanowska et al., 2005;
van der Laan et al., 2008). However, weight loss is not a reliable predictor
of infection outcome or survival asmice can readily recover losses of 25–
30%of bodyweight.Moreover, it is not knownhowweight loss correlates
with the extent of lung pathology and the lung-speciﬁc immuneversity of Maryland School of
St., Baltimore, MD 21201, USA.
(D. Verhoeven),
ll rights reserved.response. Pulse-oximetry provides a measure of lung function and
blood oxygenation determined by spectrophotometric analysis of the
percent of oxygenatedhemoglobin (Wahret al.,1995). In humans, pulse-
oximeters provide an important clinical readout of morbidity in
respiratory diseases; however, human pulse-oximeters have not been
readilyadapted to analyze animalmodels of disease (Sidwell et al.,1992).
In this study, we hypothesized that morbidity and outcome of
inﬂuenza virus infection could be better predicted by measuring lung
function parameters compared to systemic weight loss. We used a
newly developed pulse-oximeter adapted for use in rodents, to follow
the progress of inﬂuenza infection according to variations in viral load
and host immune status. We found that SpO2 levels directly correlated
with lung pathology at all stages of infection, and allowed more ﬁne-
tuned assessment of the effect of viral dose on outcome compared to
weight-loss parameters alone. In addition, we found that SpO2 levels
were proportional to the efﬁcacy of the immune response in
immunodeﬁcient mice and in mice presensitized to inﬂuenza,
where weight loss failed to predict infection outcome. Our results
indicate that SpO2 levels provide a valuable non-invasive assessment
of lung function and pathology, and a superior predictor of morbidity
and mortality from respiratory viral disease.
Results
Oxygen saturation levels and initial infectious dose
To assess whether oxygen saturation levels in the blood could be
useful indicators of the severity of inﬂuenza infection, we infected
Fig. 1. Oxygen saturation levels correlate with the amount of viral replication in the
lungs in murine models of inﬂuenza infection. BALB/c mice were infected with 0, 10,
100, or 1000 TCID50 of inﬂuenza strain A/PR8/34 andmonitored for weight loss, oxygen
saturation and viral titers for a 12 day infectious period. (A) Graph shows percent of
starting weight of mice infected with 10, 100 or 1000 TCID50 of inﬂuenza from 1 to
7 days post-infection. (B) Inﬂuenza replication was measured by MDCK assay at day 5,
day 7, and day 12 post-infection in mice infected with different inﬂuenza doses.
Signiﬁcant differences were found at day 3 post-infection indicated by ⁎ (p=0.03) and
day 7 post-infection indicated by ⁎⁎ (p=0.02) (n=10, +/−SE). (C) Graph shows
oxygen saturation levels (SpO2) as determined by pulse-oximetry (see Materials and
methods) at days 3 and 7 post-infection. Signiﬁcant differences were found for groups
at day 3 post-infection indicated by ⁎ (pb0.001), day 5 post-infection indicated by
⁎⁎ (pb0.001), day 7 post-infection indicated by ⁎⁎⁎ (p=0.003), and day 12 post-
infection indicated by ⁎⁎⁎⁎ (pb0.001). (Each value is an average±SE of values from
two experiments, n=5 per group per experiment).
152 Rapid CommunicationBALB/cmice intranasallywith increasing doses from10 to 1000 TCID50
of inﬂuenza A/PR8/34 (PR8) virus, and assessed both weight loss and
SpO2 levels during the course of infection. We previously determined
that doses of 10 TCID50 and100TCID50were sub-lethal infectious doses
with full recovery of weight loss within 10–14 days post-infection,
while ≥1000 TCID50 constituted a lethal dose (2LD50), with mortality
occurring within 15 days post-infection (data not shown). Measure-
ments of weight loss during the course of infection showed that mice
infected with a 10 TCID50 dose lost only a moderate amount of weight
and began to recover weight after day 7 post-infection, reaching the
startingweight by day 9 post-infection. By contrast, mice infectedwith
100 or 1000 TCID50 doses both exhibited similar precipitous weight
loss of 30% of their startingweight by day 8 post-infection, after which
responses to these two infectious doses diverged.Whereas 100 TCID50-
infected mice beginning to recover weight at day 10 post-infection,
1000 TCID50-infected mice lost additional weight falling to b70% of
their starting weight, which remained low throughout the infection
period (day 12 post-infection) (Fig. 1A).
We examined how viral replication correlated to weight loss in the
differentially infected mice by assessing lung viral titers at day 5 post-
infection representing the peak of viral replication, day 7 representing
the initial drop in viral titers, and day 12 representing the clearance
stage of viral replication (Jelley-Gibbs et al., 2007). At day 5, the lung
viral titers were proportional to the initial viral doses with mice
infected with 10 TCID50 of PR8 having the lowest viral titers, followed
by 100 TCID50-infected mice, with 1000 TCID50-infected mice having
the highest lung viral load that was 50 fold higher than mice infected
with 100 TCID50 (Fig.1B). At day 7 post-infection, lung viral titers in the
100 and 1000 TCID50-infected mice were still 4 orders of magnitude
greater than viral loads in 10 TCID50-infected mice which had already
cleared the majority of the virus. However, by day 12 post-infection,
virus was not detected in the lungs of all infected groups indicating
viral clearance (Fig. 1B). These results show that while the peak viral
load in the lung was proportional to the initial infectious dose, the
kinetics of complete viral clearance was similar in mice receiving both
sub-lethal and lethal inﬂuenza doses.
The disparities between weight loss, viral dose and viral titers at
different timepoints emphasized the need for additional readouts of
clinical outcome during inﬂuenza infection. We evaluated oxygen
saturation levels in each mouse group receiving different infectious
doses at intervals from day 0 to 12 post-infection using a rodent-
adapted pulse-oximeter (MouseOx). Mock infected mice maintained
near 100% SpO2, as expected, as any decrease in SpO2 less than 95% is
considered grave in human patients (Wahr et al., 1995). Inﬂuenza-
infected mice at all doses exhibited marked decreases in SpO2
levels starting at day 3 until day 7 post-infection with the reduction
in SpO2 level proportional to the infectious dose. At day 7 post-
infection, 10 and 100 TCID50-infected mice exhibited 93% and b90%
SpO2, respectively, with 1000 TCID50-infected mice having b85% SpO2
indicating severe hypoxia (Fig. 1C). These results demonstrate that at
day 7 post-infection, when the difference inweight loss and viral titers
was not signiﬁcant between 100 and 1000 TCID50-infected mice, SpO2
levels were more accurate indicators of the lung viral load.
At later timepoints post-infection, SpO2 levels were particularly
informative with regard to recovery from infection after virus was
cleared. By day 12 post-infectionwhen virus was cleared in all groups,
both 10 and 100 TCID50 infectedmice still maintained lower SpO2 than
pre-infection levels with 10 TCID50 having 95% and 100 TCID50-
infected exhibiting SpO2 levels b94% (Fig. 1C), despite having
recoveredmost of their starting weight. SpO2 levels were dramatically
decreased in 1000 TCID50-infected mice to b80% at 12 days post-
infection, indicating severe hypoxia and irreversible morbidity (Fig.
1C), and consistent with continued weight loss. These results indicate
that SpO2 measurements can provide an assessment of continuing
pathological damage in the lung after virus is cleared although mice
are recovering weight.Oxygen saturation levels indicate lung pathology
The results above suggested that SpO2 measurements may
indicate the level of lung pathology. We therefore analyzed pathology
in lung tissue sections obtained from mice infected with different
doses of inﬂuenza at 5, 7 and 12 days post-infection (Fig. 2). At day 5
post-infection, mice that received 10 TCID50 exhibited desquamation
of the alveolar epithelium in response to virus infection (Fig. 2A)
with minimal leukocyte inﬁltration into interstitial tissues and
minimal lung consolidation as compared to uninfected controls
(Fig. 2J). Leukocyte inﬁltration and lung consolidation increased by
day 7 post-infection in 10 TCID50-infected mice (Fig. 2D), but was
Fig. 2. Oxygen saturation levels mirror the level of lung pathology during inﬂuenza infection. H&E staining of lungs of mice infected with (A) 10 TCID50, (B) 100 TCID50, or (C)
1000 TCID50, PR8 inﬂuenza virus at 5 days post-infection as compared to mice infected with (D) 10 TCID50, (E) 100 TCID50, (F) and 1000 TCID50 at 7 days post-infection or with
the lungs of (G) 10 TCID50, (H) 100 TCID50, and (I) 1000 TCID50 infected mice at 12 days post-infection as compared to uninfected controls (J). One representative animal of ﬁve
is shown for each group.
Table 1







SpO2 after heating (%)
(p=0.08)
1 32.2/37.6 79 83
2 33.7/36.8 81 86
3 32.5/36.1 73.1 75
4 33.9/37.6 79.6 86
5 32.6/35.0 82.5 85.6
Direct application of
heat to leg: mouseb
Rectal temperature SpO2 before
heating (%)
SpO2 after heating (%)
(p=0.45)
1 33.8 82 83
2 32.5 81 79
3 33.06 76 74
4 32.6 81 85
a Mice were warmed under a heating lamp for 3 min, and pulse-oximetry readings
taken prior to and following heating.
b Heating pads were applied to the leg and warmed for 3 min, and pulse-oximetry
readings taken prior to and following heating.
153Rapid Communicationresolved at day 12 post-infection (Fig. 2G) when lung architecture
resembled uninfected controls with the exception of small,
dispersed regions within the interstitial tissue. In 100 TCID50-
infected mice, increased leukocyte inﬁltration was observed at day
5 post-infection with mild disruption of normal alveoli structure
compared to uninfected or 10 TCID50-infected mice. The observed
pathology in 100 TCID50-infected mice increased through day 7
post-infection with an greater number of occluded alveolar spaces
(Fig. 2E), and by day 12 post-infection there were some alveolar
epithelium that continued to exhibit desquamation along with
areas that returned to normal morphology (Fig. 2H). Mice infected
with 1000 TCID50 exhibited more intensive leukocyte inﬁltration
with condensation appearing around the bronchioles and epithelial
sloughing within the larger airways and alveoli compared to the
other groups at 5 days post-infection (Fig. 2C). The level of inﬁl-
tration and consolidation coincident with alterations in alveolar
architecture continued to increase by day 7 post-infection (Fig. 2F)
exhibiting the most severe pathology at day 12 post-infection
(Fig. 2I), when the lungs were heavily consolidated with minimal
normal lung architecture. These results demonstrate that the ob-
served oxygen saturation levels not only matched the early viral
replication detected in each group, but also appeared to better
correlate with the actual pathology in the lung tissue even after
viral clearance.
Effect of temperature on peripheral oxygen saturation levels
Because pulse-oximetry readings depend on the level of blood ﬂow
which can be altered by temperature, and inﬂuenza infection in mice
has been shown to lead to a temperature drop (Jhaveri et al., 2007),we compared SpO2 levels in lethally challenged mice (1000 TCID50)
prior to and after application of systemic or locally applied heat. As
compared to uninfected mice, inﬂuenza infection resulted in
decreased body temperature (average of 3.8 °C) and average SpO2 of
79%. Heating of mice to raise their body temperature to the level of
uninfected controls, resulted in slightly increased levels of oxygen
saturation levels to an average of 83.3%, that was not statistically
different from unheated infected mice (Table 1). To limit the effects of
vasodilatation in the lungs contributing to increased oxygen satura-
tion after systemically applied heating, heat packs were applied to the
154 Rapid Communicationleg used to measure oxygen saturation. We determined that 3 min of
direct warming to the leg led to vasodilatation in saphenous veins
(data not shown). As shown in Table 1, lethally challenged mice (1000
TCID50) had no change in the SpO2 levels after heating (80.2%)
compared to SpO2 levels prior to heating (80%). These data
demonstrate that the decreased SpO2 levels observed in inﬂuenza-
infected mice are not appreciably altered by warming.
Oxygen saturation as a non-invasive readout of the immune response
The immune response to inﬂuenza infection determines the
outcome of infection, by providing viral clearance in the lung,
contributing to the systemic inﬂammatory response, and also can
promote immunopathology. We asked whether SpO2 would also
provide a more accurate readout for the efﬁcacy of the host immune
response driving viral clearance in the lungs. We assessed weight
loss, viral load, and SpO2 measurements in intact naive mice at the
100 TCID50 dose compared to a similar infectious dose in RAG2-
deﬁcient (RAG2−/−) mice lacking an adaptive immune response,
and mice that received inﬂuenza-speciﬁc memory T cells obtained
from mice which were previously infected and had cleared an
inﬂuenza infection. With these groups, we could determine the
contribution of the innate immune system or adaptive memory
responses to weight loss and oxygen saturation levels after infection.
Interestingly, RAG2−/− mice lost the least amount of weight as
compared to infected naive and memory mice both of which
exhibited comparable weight-loss morbidity up to day 7 post-
infection (Fig. 3A). These relative weight-loss measurements did not
correlate to the viral load in these mouse groups. Compared to the
viral loads in 100 TCID50-infected intact mice, RAG2−/− mice
exhibited the highest viral loads in the lung, consistent with their
lack of an adaptive immune response that results in eventual death
by viremia (Bot et al., 1996), and mice with memory T cells had theFig. 3. Immune response suppression of viral replication leads correlates with levels of o
recipients of inﬂuenza-primed memory T cells (“Memory”) were infected with 100TCID50
starting weight of naive, RAG2−/− and memory mice infected with 100 TCID50 inﬂuenza f
group per experiment +/− SE). (B) Lung viral titers in the different mouse groups as deter
differences were found between all three groups indicated by ⁎ (p=0.03). (C) Oxygen sat
Signiﬁcant differences were found for groups at day 3 post-infection indicated by ⁎ (pb0.001
naive mice (top) and RAG2−/− mice (bottom) infected with 100 TCID50 of PR8 inﬂuenza atlowest viral loads (Fig. 3C), consistent with the ability of memory T
cells to mediate protective immunity.
Interestingly, SpO2 levels measured by pulse-oximetry exhibited
an inverse correlation with viral loads in the lung. SpO2 in infected
RAG2−/− mice followed a similar precipitous decline observed in
intact mice infected with a lethal dose of inﬂuenza, decreasing to
near 80% at 7 days post-infection (Fig. 3B), consistent with the high
viral loads. Mice with inﬂuenza-speciﬁc memory T cells maintained
higher SpO2 levels at all timepoints post-infection compared to that
of naive infected mice (Fig. 3B), consistent with their enhanced viral
clearance. When taken together, assessing multiple parameters
during inﬂuenza infection reveals that SpO2 levels provide an
accurate indicator of the efﬁcacy of the immune response, whereas
weight-loss measurements did not reﬂect the ability of mice differing
in immune status to clear the infection. In the case of RAG2−/−
immune-deﬁcient mice, the lack of substantial weight-loss morbidity
was paradoxical with the high viral load and poor outcome, and the
rapid weight loss of mice with preformed memory T cell immunity to
inﬂuenza did not accurately reﬂect the increased viral clearance in
these mice.
To assess whether SpO2 levels likewise indicated the level of
lung pathology in immune competent versus immune-deﬁcient
mice, we compared lung sections stained by H&E in 100 TCID50
infected intact mice and RAG2−/− mice at 7 days post-infection. As
before, we found that intact mice infected with 100 TCID50 had
moderate levels of leukocyte inﬁltration, disruption of normal
alveolar architecture, and mild lung consolidation (Fig. 3D, top). In
stark contrast, inﬂuenza-infected RAG2−/− mice had severe lung
consolidation throughout most of the tissue and extensive inﬁltra-
tion of polynuclear and mononuclear leukocytes which occluded the
airway architecture (Fig. 3D, bottom). These results show that SpO2
levels served as accurate indicators of the severity of lung patho-
logy as well as viral clearance in mice of different immune status,xygen saturation. Naive BALB/c mice (“Naive”), RAG2−/− mice, and BALB/c mouse
of inﬂuenza strain A/PR8/34 and monitored as in Fig. 1. (A) Graph shows percent of
rom 1 to 7 days post-infection. (data are compiled from two experiments of n=5 per
mined by the MDCK killing assay at 7 days post-infection (n=10, +/−SE). Signiﬁcant
uration levels (SpO2) as determined by pulse-oximetry at days 3 and 7 post-infection.
), and at day 7 post-infection indicated by ⁎⁎ (p=0.007). (D) H&E staining of lungs from
7 days post-infection. A representative animal is shown for each group.
155Rapid Communicationwhereas weight-loss measurements did not reﬂect the lung-speciﬁc
response.
Discussion
The outcome of respiratory viral infections such as inﬂuenza
depends on multiple parameters including the extent of virus-
associated pathology in the lung, and the local and systemic im-
mune and inﬂammatory response. Treating established infections
will require knowledge of the pathogenesis of infection and the
extent of inﬂammation and immunopathology. Currently, readouts
of infection in animal models rely chieﬂy on systemic weight-loss
measurements to indicate virus-induced morbidity and predict
infection outcome. Here, we used a pulse-oximeter adapted for use
in mice to assess how oxygen saturation levels could serve as an
indicator and predictor of the outcome of inﬂuenza infection. Our
results demonstrate that measurement of SpO2 by pulse-oximetry
accurately reﬂects the pathologic conditions in the lung during
viral infection and is a reliable indicator of the efﬁcacy of the host
immune response in the lung. By contrast, weight-loss measure-
ments did not correlate with differences in viral load prior to
clearance and were ineffective in predicting the pathology in the
lungs during infection.
Measuring oxygen saturation is a reliable and consistent tool that is
superior to other systems due to its ease of application and
reproducibility. Although sacriﬁcing animals with a weight loss of
N25% of initial starting weight is typically utilized in murine models of
respiratory infections and generally predicts animals that will not
survive infection, mice with pre-existing memory T cells to inﬂuenza
exhibited a signiﬁcant weight loss, yet controlled viral replication.
Therefore, weight loss alone does not predict the severity of inﬂuenza
infection but when used in conjunction with oxygen saturation, a
better assessment of morbidity and mortality can be obtained.
Traditional approaches to monitor lung function in mice using
plethysmography to assess bronchial resistance to oxygen diffusion
can be inaccurate (Bates et al., 2004) and thus are not adaptable as
reliable predictors of disease outcome.
Inﬂuenza infection drives a strong adaptive immune response
that not only acts to clear virus, but can also result in immuno-
pathology either systemically through the release of inﬂammatory
mediators, and/or locally through the recruitment of immune
effectors to the lung. The limited amount of weight loss observed
in the RAG2−/− mice, as compared to infected BALB/c mice,
indicates that weight-loss pathology is associated with an adaptive
response to infection, that has also been shown in other models
such as RSV, murine pneumonia virus, and metapneumovirus with
secondary bacterial infections (Bueno et al., 2008; Frey et al., 2008;
Kukavica-Ibrulj et al., 2009). Indeed, mortality from pandemic
strains of inﬂuenza has been attributed to an overzealous immune
response (Kash et al., 2006). Here, we demonstrate lung immuno-
pathology following viral clearance, particularly in mice infected
with higher viral doses. Paradoxically, the lowest SpO2 levels in
1000 TCID50-infected mice were observed after viral clearance,
suggesting an immune response may have contributed to lung
damage. It has been shown that following inﬂuenza infection of
mice, antigen depots persist in the lung and lymphoid tissue (Jelley-
Gibbs et al., 2007; Zammit et al., 2006), which may continue to
drive immune activation leading to continued lung inﬂammation as
seen here in all infected groups. SpO2 levels can accurately indicate
immunopathology in the lung long after virus is cleared, with
important implications for using mouse models to design ther-
apeutic interventions for treating the deleterious consequences of
the immune response to viral infections.
SpO2 readings clearly and strikingly followed the level of pathology
in the lungs and the immune response demonstrating its utility for
assessing the amount of lung inﬂammation without having the needfor sacriﬁcing animals during early infection timepoints. Since
respiratory viral infections can cause signiﬁcant pathology in the
lungs of murine models of infection, measuring oxygen saturation
should prove to be an optimal tool for correlating virus titers and lung
pathology and obtaining a better assessment for modeling viral
infections in murine models.
Materials and methods
Mice
BALB/c female mice 6 weeks of age were purchased from the
National Cancer Institute Biological Testing Branch and housed at the
animal facility at the University of Maryland School of Medicine.
RAG2−/− mice on BALB/c background (Taconic Farms, Germantown,
MD) were bred and maintained at the animal facility. All animal
procedures were approved by the Institutional Animal Care and Use
committee at University of Maryland, Baltimore.
Inﬂuenza infection of mice
Inﬂuenza virus strain A/PR8/34 was grown in the allantoic ﬂuid of
chicken eggs as described (Gerhard,1976). Intranasal infection of mice
with doses from 10 to 1000 TCID50 was performed on anesthetized
mice. To generate inﬂuenza-speciﬁc memory T cells, mice were
infected with 100 TCID50 of inﬂuenza and allowed to recover. T cells
were isolated by negative selection from the spleens of these mice
10 weeks post-infection, and transferred (2×106cells/mice) intrave-
nously into BALB/c hosts and challenged with 100 TCID50 of inﬂuenza
A/PR8/34 one day after cell transfer.
Oxygen saturation measurements
The MouseOx™ Pulse-oximeter (Starr Life Sciences, Oakmont PA)
was used to measure blood SpO2 on mice 3 and 7 days post-infection.
Micewere held by hand and the pulse-oximeter clip was placed on the
hind leg. Mice were held and covered by the light blocker fabric
supplied by the manufacturer and held until calm (several seconds),
before placing the probe on the hind leg over the skin near the femur
bone. In some cases, removal of the hair on the hind legs by shaving or
the use of a depilatory agent was necessary to achieve 100% oxygen
saturation levels in uninfected mice (data not shown). Three minute
readings were taken from each mouse, sorted by spreadsheet for
readings that had no error codes in a block, and the average of 25–50
individual readings was calculated. In additional experiments, the
entire body of mice was heated for 3 min with a heat lamp or a heat
pack (HeatMax) was applied directly to the leg of mice for 3 min
before immediately reading oxygen saturation levels.
Inﬂuenza viral titer measurement
Viral titers were assayed using the MDCK killing assay as described
(Gerhard, 1976). MDCK cells were plated to 85% conﬂuency the day
before titer determination. Lung tissue from snap frozen tissue of
equal weight was serial diluted in DMEM. MDCKwere infected for 2 h,
washed twice, and DMEM containing 0.5% bovine serum albumin
(Sigma) and 1 μg/ml of trypsin-TPK was added to each well. Three
days post-infection, supernatants were harvested and virus quantiﬁed
by HAI assay (Gerhard, 1976).
Immunohistochemistry
The left lobes of the lungs from infected mice were perfused with
4% formalin and then dissected and immersed in formalin. Five μM
sections of lungs were stained with H&E, and examined by light
microscopy.
156 Rapid CommunicationStatistics
ANOVA analysis or Student T-tests were used to compare each
group using a conﬁdence interval of 95%. Mann–Whitney U Test was
used to compare oxygen saturation before and after heating using a
conﬁdence interval of 95%.
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